Chiroscience, Pharmacia AB deal

CRO (Cambridge, U.K.) and Pharmacia (Uppsala, Sweden) will develop CRO's levobupivacaine anesthetic, a single-isomer version of bupivacaine, which is in two Phase II/III trials. CRO, which retained ma...